Alumni raised $1.45B in 2022 - Download Free Report Now


Embolic prevention systems/thrombus management technologies and neurovascular devices.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of InspireMD (NYSE:NSPR) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About InspireMD (NYSE:NSPR)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

Competing Startups


Companies We Work With